Methyl 4-hydroxy-3,5-dimethoxycinnamate; Sinapic acid methyl ester

Details

Top
Internal ID e1e6a203-e6b6-4108-9f3b-171ef0a820a4
Taxonomy Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Hydroxycinnamic acids and derivatives > Coumaric acids and derivatives
IUPAC Name methyl 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
SMILES (Canonical) COC1=CC(=CC(=C1O)OC)C=CC(=O)OC
SMILES (Isomeric) COC1=CC(=CC(=C1O)OC)C=CC(=O)OC
InChI InChI=1S/C12H14O5/c1-15-9-6-8(4-5-11(13)17-3)7-10(16-2)12(9)14/h4-7,14H,1-3H3
InChI Key JHLPYWLKSLVYOI-UHFFFAOYSA-N
Popularity 17 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H14O5
Molecular Weight 238.24 g/mol
Exact Mass 238.08412354 g/mol
Topological Polar Surface Area (TPSA) 65.00 Ų
XlogP 1.80
Atomic LogP (AlogP) 1.60
H-Bond Acceptor 5
H-Bond Donor 1
Rotatable Bonds 4

Synonyms

Top
SCHEMBL2517008
methyl 3,5-dimethoxy-4-hydroxycinnamate

2D Structure

Top
2D Structure of Methyl 4-hydroxy-3,5-dimethoxycinnamate; Sinapic acid methyl ester

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9869 98.69%
Caco-2 + 0.7775 77.75%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.5571 55.71%
Subcellular localzation Mitochondria 0.8067 80.67%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9085 90.85%
OATP1B3 inhibitior + 0.9672 96.72%
MATE1 inhibitior - 0.7200 72.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.6021 60.21%
P-glycoprotein inhibitior - 0.9473 94.73%
P-glycoprotein substrate - 0.8989 89.89%
CYP3A4 substrate - 0.6153 61.53%
CYP2C9 substrate - 0.6043 60.43%
CYP2D6 substrate - 0.8380 83.80%
CYP3A4 inhibition - 0.8462 84.62%
CYP2C9 inhibition - 0.9871 98.71%
CYP2C19 inhibition - 0.9155 91.55%
CYP2D6 inhibition - 0.9569 95.69%
CYP1A2 inhibition - 0.9299 92.99%
CYP2C8 inhibition - 0.6192 61.92%
CYP inhibitory promiscuity - 0.8290 82.90%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.7340 73.40%
Carcinogenicity (trinary) Non-required 0.6140 61.40%
Eye corrosion - 0.7485 74.85%
Eye irritation + 0.9814 98.14%
Skin irritation - 0.5159 51.59%
Skin corrosion - 0.9806 98.06%
Ames mutagenesis - 0.8500 85.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7656 76.56%
Micronuclear + 0.5507 55.07%
Hepatotoxicity - 0.7198 71.98%
skin sensitisation - 0.8767 87.67%
Respiratory toxicity - 0.7889 78.89%
Reproductive toxicity + 0.7170 71.70%
Mitochondrial toxicity - 0.8750 87.50%
Nephrotoxicity - 0.6831 68.31%
Acute Oral Toxicity (c) II 0.4544 45.44%
Estrogen receptor binding + 0.7126 71.26%
Androgen receptor binding - 0.5288 52.88%
Thyroid receptor binding - 0.5478 54.78%
Glucocorticoid receptor binding - 0.7509 75.09%
Aromatase binding - 0.5219 52.19%
PPAR gamma - 0.6914 69.14%
Honey bee toxicity - 0.9289 92.89%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity + 0.9627 96.27%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.30% 91.11%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 95.63% 96.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.72% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 91.35% 86.33%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.35% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 84.20% 89.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.44% 99.17%
CHEMBL3401 O75469 Pregnane X receptor 81.99% 94.73%
CHEMBL3194 P02766 Transthyretin 81.55% 90.71%
CHEMBL1255126 O15151 Protein Mdm4 81.26% 90.20%

Cross-Links

Top
PubChem 159894
NPASS NPC160633
LOTUS LTS0095510
wikiData Q105128076